Gene delivery using polyethylenimine and copolymers

Polymeric Gene Delivery: Principles and Applications

Volumn , Issue , 2004, Pages 97-106

  Ogris, Manfred ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84945255091     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203500477     Document Type: Chapter

References (81)

1. Boussif, O. et al., A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine, Proc. Nat. Acad. Sci. U.S.A. 92, 7297, 1995.
2. Kichler, A., Behr, J.P., and Erbacher, P., Polyethylenimines: a family of potent polymers for nucleic acid delivery, in Nonviral Vectors for Gene Therapy, Huang, L., Hung, M.C., and Wagner, E. (Eds.), Academic Press, San Diego, 1999, Chapter 9.
3. Suh, J., Paik, H.J., and Hwang, P.K., Ionization of polyethylenimine and polyellylamine at various pHs, Bioorg. Chem. 22, 318, 1994.
4. Godbey, W.T., Wu, K.K., and Mikos, A.G., Poly(ethylenimine) and its role in gene delivery, J. Control. Release 60, 149, 1999.
5. Brissault, B. et al., Synthesis of linear polyethylenimine derivatives for DNA transfection, Bioconjug. Chem. 14, 581, 2003.
6. Kircheis, R. et al., Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery, Gene Ther. 4, 409, 1997.
7. Ogris, M. et al., Melittin enables efficient vesicular escape and enhanced nuclear access of non-viral gene delivery vectors, J. Biol. Chem. 12, 12, 2001.
8. Carlisle, R.C. et al., Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors, Mol. Ther. 4, 473, 2001.
9. Kursa, M. et al., Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer, Bioconjug. Chem. 14, 222, 2003.
10. Ogris, M. et al., PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery, Gene Ther. 6, 595, 1999.
11. Blessing, T. et al., Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery, Bioconjug. Chem. 12, 529, 2001.
12. Erbacher, P. et al., Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI), J. Gene Med. 1, 210, 1999.
13. Erbacher, P., Remy, J.S., and Behr, J.P., Gene transfer with synthetic virus-like particles via the integrinmediated endocytosis pathway. Gene Ther. 6, 138, 1999.
14. Ungaro, F. et al., Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations, J. Pharm. Biomed. Anal. 31, 143, 2003.
15. Tang, M.X. and Szoka, F.C., The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes, Gene Ther. 4, 823, 1997.
16. Dunlap, D. D. et al., Nanoscopic structure of DNA condensed for gene delivery, Nucleic Acids Res. 25, 3095, 1997.
17. Bettinger, T. et al., Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells, Nucleic Acids Res. 29, 3882, 2001.
18. Ogris, M. et al., The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells, Gene Ther. 5, 1425, 1998.
19. Wightman, L. et al., Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo, J. Gene Med. 3, 362, 2001.
20. Finsinger, D. et al., Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery, Gene Ther. 7, 1183, 2000.
21. Clamme, J.P., Azoulay, J., and Mely, Y., Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy, Biophys. J. 84, 1960, 2003.
22. Godbey, W.T., Wu, K.K., and Mikos, A.G., Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability, Biomaterials 22, 471, 2001.
23. Mislick, K.A. and Baldeschwieler, J.D., Evidence for the role of proteoglycans in cation-mediated gene transfer, Proc. Nat. Acad. Sci. U.S.A. 93, 12349, 1996.
24. Bieber, T. et al., Intracellular route and transcriptional competence of polyethylenimine-DNA complexes, J. Control. Release 82, 441, 2002.
25. Ruponen, M. et al., Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes, J. Biol. Chem. 276, 33875, 2001.
26. Ferrari, S. et al., ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo, Gene Ther. 4, 1100, 1997.
27. Brunner, S. et al., Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus, Gene Ther. 7, 401, 2000.
28. Ogris, M. et al., DNA/polyethylenimine transfection particles: Influence of ligands, polymer size, and PEGylation on internalization and gene expression, AAPS PharmSci. 3, E21, 2001.
29. Kunath, K. et al., Integrin targeting using RGD-PEI conjugates for in vitro gene transfer, J. Gene Med. 5, 588, 2003.
30. Suh, W. et al., An angiogenic, endothelial-cell-targeted polymeric gene carrier, Mol. Ther. 6, 664, 2002.
31. Zabner, J. et al., Cellular and molecular barriers to gene transfer by a cationic lipid, J. Biol. Chem. 270, 18997, 1995.
32. Labat Moleur, F. et al., An electron microscopy study into the mechanism of gene transfer with lipopolyamines, Gene Ther. 3, 1010, 1996.
33. Kichler, A. et al., Polyethylenimine-mediated gene delivery: a mechanistic study, J. Gene Med. 3, 135, 2001.
34. Akinc, A. and Langer, R., Measuring the pH environment of DNA delivered using nonviral vectors:implications for lysosomal trafficking, Biotechnol. Bioeng. 78, 503, 2002.
35. Baker, A. et al., Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery, Gene Ther. 4, 773, 1997.
36. Lee, H., Jeong, J.H., and Park, T.G., A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide, J. Control. Release 76, 183, 2001.
37. Lukacs, G. L. et al., Size-dependent DNA mobility in cytoplasm and nucleus, J. Biol. Chem. 275, 1625, 2000.
38. Pollard, H. et al., Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells, J. Biol. Chem. 273, 7507, 1998.
39. Suh, J., Wirtz, D. and Hanes, J., Efficient active transport of gene nanocarriers to the cell nucleus, Proc. Nat. Acad. Sci. U.S.A. 100, 3878, 2003.
40. Brunner, S. et al., Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation, Mol. Ther. 5, 80, 2002.
41. Saphire, A. C. et al., Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70, J. Biol. Chem. 275, 4298, 2000.
42. Ogris, M. et al., Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors, J. Biol. Chem. 276, 47550, 2001.
43. Abdallah, B. et al., A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine, Hum Gene Ther. 7, 1947, 1996.
44. Goula, D. et al., Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system, Gene Ther. 5, 712, 1998.
45. Shi, L. et al., Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord, Gene Ther. 10, 1179, 2003.
46. Gharwan, H. et al., Nonviral gene transfer into fetal mouse livers (a comparison between the cationic polymer PEI and naked DNA), Gene Ther. 10, 810, 2003.
47. Boletta, A. et al., Nonviral gene delivery to the rat kidney with polyethylenimine, Hum Gene Ther. 8, 1243, 1997.
48. Foglieni, C. et al., Glomerular filtration is required for transfection of proximal tubular cells in the rat kidney following injection of DNA complexes into the renal artery, Gene Ther. 7, 279, 2000.
49. Gautam, A. et al., Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery, Mol. Ther. 2, 63, 2000.
50. Rudolph, C. et al., Nonviral gene delivery to the lung with copolymer-protected and transferrinmodified polyethylenimine, Biochim. Biophys. Acta 1573, 75, 2002.
51. Coll, J.L. et al., In vivo delivery to tumors of DNA complexed with linear polyethylenimine, Hum Gene Ther. 10, 1659, 1999.
52. Goula, D. et al., Polyethylenimine-based intravenous delivery of transgenes to mouse lung, Gene. Ther. 5, 1291, 1998.
53. Nguyen, H.K. et al., Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents, Gene Ther. 7, 126, 2000.
54. Oupicky, D. et al., Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation, Mol. Ther. 5, 463, 2002.
55. Chollet, P. et al., Side-effects of a systemic injection of linear polyethylenimine-DNA complexes, J. Gene Med. 4, 84, 2002.
56. Oh, Y.K. et al., Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes, Gene Ther. 8, 1587, 2001.
57. Lecocq, M. et al., Uptake and intracellular fate of polyethylenimine in vivo, Biochem. Biophys. Res. Commun. 278, 414, 2000.
58. Sweeney, P. et al., Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model, Cancer Res. 63, 4017, 2003.
59. Kren, B.T. et al., Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide, Proc. Nat. Acad. Sci. U.S.A. 96, 10349, 1999.
60. Kren, B.T., Bandyopadhyay, P., and Steer, C.J., In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides, Nat. Med. 4, 285, 1998.
61. Kren, B. T. et al., Modification of hepatic genomic DNA using RNA/DNA oligonucleotides, Gene Ther. 9, 686, 2002.
62. Aigner, A. et al., Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression, Gene Ther. 9, 1700, 2002.
63. Robaczewska, M. et al., Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver, Gene Ther. 8, 874, 2001.
64. Ogris, M. and Wagner, E., Targeting tumors with non-viral gene delivery systems, Drug Discov. Today 7, 479, 2002.
65. Dolivet, G. et al., In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector, Cancer Gene Ther. 9, 708, 2002.
66. Gautam, A., Densmore, C.L., and Waldrep, J.C., Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes, Mol. Ther. 2, 318, 2000.
67. Densmore, C. L. et al., Growth suppression of established human osteosarcoma lung metastases in mice by aerosol Gene Ther. with PEI-p53 complexes, Cancer Gene Ther. 8, 619, 2001.
68. Kircheis, R. et al., Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity, Cancer Gene Ther. 9, 673, 2002.
69. Vernejoul, F. et al., Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models, Cancer Res. 62, 6124, 2002.
70. Zanta, M.A. et al., In vitro gene delivery to hepatocytes with galactosylated polyethylenimine, Bioconjug. Chem. 8 (6), 839, 1997.
71. Bettinger, T., Remy, J.S., and Erbacher, P., Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes, Bioconjug. Chem. 10, 558, 1999.
72. Morimoto, K. et al., Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver, Mol. Ther. 7, 254, 2003.
73. O’Neill, M.M. et al., Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine, Gene Ther. 8, 362, 2001.
74. Wolschek, M.F. et al., Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice, Hepatology 36, 1106, 2002.
75. Lee, H., Kim, T.H. and Park, T.G., A receptor-mediated gene delivery system using streptavidin and biotin-derivatized, pegylated epidermal growth factor, J. Control. Release 83, 109, 2002.
76. Guo, W. and Lee, R.J., Receptor-targeted gene delivery via folate-conjugated polyethylenimine, AAPS PharmSci. 1, Article 19, 1999.
77. Benns, J.M., Mahato, R.I., and Kim, S.W., Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine, J. Control. Release 79, 255, 2002.
78. Diebold, S.S. et al., Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells, J. Biol. Chem. 274, 19087, 1999.
79. Li, S. et al., Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody, Am. J. Physiol. Lung Cell Mol. Physiol. 278, L504-L511, 2000.
80. Muller, K. et al., Highly efficient transduction of endothelial cells by targeted artificial virus-like particles, Cancer Gene Ther. 8, 107, 2001.
81. Boeckle, S. et al., Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer, J. Gene Med., in press, 2004.